- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A Gardasil press release and related PR emails after the UK HPV tender were ruled misleading and exaggerated, including superiority and “vaccine…
A rheumatologist complained that an RCP webcast sponsored by Roche effectively promoted rituximab. The Panel found sponsorship was transparent and arm’s length,…
Procter & Gamble complained that Servier promoted unbalanced messages implying acid suppressants increased fracture risk and reduced bisphosphonate efficacy. The Panel and…
The MHRA complained that a Zoladex journal advertisement referenced the MHRA. The Panel ruled this breached Clause 9.5 because such references are…
Anonymous complaint alleged Merck Serono encouraged off-licence promotion of Pergoveris via internal emails targeting Menopur IVF/ICSI cycles. Panel found emails unclear on…
Anonymous complaint questioned GSK’s POINTS COPD audit service (consent complexity, data access, inducement). PMCPA found clear separation of promotional/non-promotional roles and no…
Abbott admitted a rep’s Synagis email to HCPs was promotional but uncertified, lacked prescribing info, included an off-licence JCVI recommendation, and was…
ProStrakan’s withdrawn Abstral ad reappeared in the BMJ after prior undertakings. Panel found breaches of Clauses 25 and 9.1 due to inadequate…
Duac materials implied use beyond mild–moderate acne, claimed it “starts working within a week” without evidence <7 days, and a sponsored GP…
Complaint alleged cumulative recent Gaviscon Advance breaches brought the industry into disrepute (Clause 2). Panel noted prior breaches but ruled no breach…
PMCPA case summary: Procter & Gamble made a voluntary admission. The published case text provided here contains no details of the allegation,…
GP alleged undue sales pressure and misleading statements about other practices switching to Fostair and PCT support. Panel found evidence insufficient to…
A pharmacist alleged a Pfizer commercial account manager discussed losartan pricing before it was licensed. Panel noted a price list included unlicensed…
Anonymous GP alleged BMS reps pushed GPs to prescribe Onglyza for set patient numbers and text when targets met. Panel found insufficient…
A contract rep arranged and mis-described a nurse-led COPD patient review service as a speaker meeting. No written agreement or records; patients…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.